Ann-joy K. Cheng
Taoyuan, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 55 publications
Refining M1-Stage Stratification in De Novo Metastatic Nasopharyngeal Carcinoma Using 18F-FDG PET/CT: Preliminary Evidence.
Journal: Clinical nuclear medicine
Published: August 24, 2025
LUCAT1 drives arecoline-induced head and neck cancer progression via STAT1-mediated transcriptional regulation.
Journal: Cellular & molecular biology letters
Published: June 26, 2025
Drug repurposing targeting miRNA-mRNA networks to mitigate areca nut-induced head and neck cancer.
Journal: Biomedical journal
Published: March 01, 2025
MiRNA Profiling of Areca Nut-Induced Carcinogenesis in Head and Neck Cancer.
Journal: Cancers
Published: September 19, 2024
Impacts of Employment Status, Partnership, Cancer Type, and Surgical Treatment on Health-Related Quality of Life in Irradiated Head and Neck Cancer Survivors.
Journal: Cancers
Published: August 23, 2024
Molecular Signature of Long Non-Coding RNA Associated with Areca Nut-Induced Head and Neck Cancer.
Journal: Cells
Published: January 22, 2023
Tumor Suppressor miRNA-503 Inhibits Cell Invasion in Head and Neck Cancer through the Wnt Signaling Pathway via the WNT3A/MMP Molecular Axis.
Journal: International journal of molecular sciences
Published: September 02, 2022
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial.
Journal: Annals of oncology : official journal of the European Society for Medical Oncology
Published: September 01, 2022
Potential to Eradicate Cancer Stemness by Targeting Cell Surface GRP78.
Journal: Biomolecules
Published: May 19, 2022
Last Updated: 09/26/2026